Packaged in Foil
Potassium Iodide is sensitive to any type of moisture even from
the air. It will become unstable if exposed to the least amount
of humidity. If it is stored in a bottle that is opened everyday
it will begin to decompose. The KI will disappear and you won't
know it. The IOSAT Potassium Iodide KI pill is sealed in foil
to product integrity, maximum shelf-life.
Purchasing many packs of IOSAT allows you to
store it where it is needed, your office, home, purse, and jacket.
Most of the other companies selling KI sell in bottles of 50
to 200 pills. Where do you plan on keeping this product when
you need it? IOSAT™ pills can be separated from the rest
(they're perforated) and kept in its sealed foil to store in
a wallet, child's backpack, etc. The official expiration date
of IOSAT™ is 5 years. However, because of the foil-sealed
packaging, pills manufactured 16 years ago recently tested as
effective as when originally made.
One pack of IOSAT (14 pills) is all that's
needed (and FDA approved) for a month's protection.
Don't take any more because it lead to symptoms of hypothyroidism.
It should be taken each day you are exposed to radioactive iodine.
Chances are you would never use up all 14 pills in a single
radiation emergency. The radioactive iodine would have blown
away from you and you would have escaped the immediate area.
In any case, since radioactive iodine has a half-life of 8 days,
it has decayed by 93% within a month's time. So, if you used
just a few pills the rest would still be sealed for any future
use.
The reason the FDA only approves Potassium Iodide
to be sold in packs of 14 pill packs is that since only the
thyroid absorbs iodine, each day you take a pill your thyroid
will receive a surge of stable iodine and effectively have
its iodine-absorption fulfilled for the day. If you continued
this regimen for 14 days your thyroid would be virtually saturated
with stable iodine and could not absorb any additional iodine
(including the radioactive type) for an additional two weeks.
Thus, a total of a month's protection for an adult.
If you were getting exposed continually to radioactive
iodine for a day or two or fourteen, doesn't it make sense
to take the only FDA-approved product that is its pills individually
sealed to keep it fresh? Try to find another company that
sells a product even closely similar.
|
RADIATION PROTECTION
IOSAT is the first radiation
protective tablet available to the general public.
Experts agree that its prompt use would be the most effective
measure available to protect millions of people who would be at
risk in a nuclear accident or under a radiation threat from a
terrorist nuclear weapon. These FDA approved tablets contain potassium
iodide (KI) which provides virtually complete protection from
radioactive iodine [ RAI ], the contaminant that causes thyroid
cancer. Should RAI ever escape, the health effects would be disastrous.
It has already happened. RAI released from the 1986 Chernobyl
nuclear accident spread throughout Europe for hundreds of miles.
According to the United Nations International Thyroid Project,
this led to over 11,000 cases of children's thyroid cancer by
the year 2000, with thousands more expected to occur before the
disease peaks in about 2010.
But investigators, including the UN, the World Health Organization
(WHO), the US FDA, the US Nuclear Regulatory Commission (NRC)
and The American Thyroid Association, uncovered the following
unexpected findings at Chernobyl:
1. Thyroid cancer was the only prominent health problem to effect
the general population. Although the accident released many types
of radioactive isotopes to the environment, all of the injuries
(to people located more than a few miles from the reactor) were
limited to just the effects of radioactive iodine. As the NRC
and WHO have reported, "except for thyroid cancer, there
has been no confirmed increase in the rates of other cancers,
including leukemia…attributed to releases from the accident.
In addition, there is no evidence of any
excess hereditary disease in children born after the accident."
In other words, the use of IOSAT
can safeguard people from most of the danger of a nuclear accident.
2. The accident was not local. Within five years of the accident,
children's thyroid cancer began appearing throughout Europe. According
to the NRC, "the vast majority of the cancers were diagnosed
among those living more than 50 km (31 miles) from the site."
Others reported identical findings, with the WHO noting, "the
increase has been documented up to 500 km from the accident site,
[and that] significant doses can occur hundreds of kilometers
beyond emergency planning zones."
At the time of the Chernobyl accident, Soviet authorities immediately
distributed large amounts of potassium iodide to people living
within 30 miles around the plant in order to neutralize the radiation.
This protection was effective. As shown below, only 3% of the
recorded cancers took place near the Chernobyl reactor. But farther
away (beyond 30 miles) almost no KI was available, and children
in these areas suffered dramatically. Without KI, children's cancer
rates soared, with 97% of the cancer taking place more than 30
miles from the reactor. Perhaps most disturbing was that 17% of
the cancer occurred more than 350 km (200 miles) distant. In Poland,
though, the government distributed
KI to every child. Poland, alone among the countries in the area,
suffered no cancer due to Chernobyl.
Back To Top
© 2001 Medical Procedures, Inc. All rights reserved.
|
|
